Home › Funds › PRENTISS SMITH & CO INC › JNJ

PRENTISS SMITH & CO INC position in JNJ

JOHNSON & JOHNSON · Health Care

PRENTISS SMITH & CO INC reported holding 35,720 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$9.5M, representing 5.35% of its reported portfolio and ranking #4 among its reported holdings. PRENTISS SMITH & CO INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.72K sh
Reported value held$9.46M
Portfolio Weight5.35%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PRENTISS SMITH & CO INC's JNJ position evolved

PRENTISS SMITH & CO INC first disclosed a stake in JNJ in Q3 2023 at 53,682 shares (US$8.4M). The position peaked in Q3 2026 at 35,720 shares, worth US$9.5M. Across 13 filings, PRENTISS SMITH & CO INC increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 35,720 shares valued at US$9.5M — a reduction of -475 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 53.68K $8.36M New
Q4 2023 48.91K $7.67M Reduce
Q1 2024 48.06K $7.60M Reduce
Q2 2024 47.88K $7.00M Hold
Q3 2024 47.84K $7.75M Hold
Q4 2024 44.30K $6.41M Reduce
Q1 2025 43.96K $7.29M Reduce
Q2 2025 42.42K $6.48M Reduce
Q3 2025 42.30K $7.84M Hold
Q4 2025 36.90K $7.64M Reduce
Q1 2026 36.37K $8.89M Reduce
Q2 2026 36.20K $9.19M Hold
Q3 2026 35.72K $9.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has PRENTISS SMITH & CO INC held JNJ?

PRENTISS SMITH & CO INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PRENTISS SMITH & CO INC's current position in JNJ?

As of Q3 2026, PRENTISS SMITH & CO INC holds 35.72K shares of JNJ (JOHNSON & JOHNSON), valued at $9.46M, representing 5.35% of its reported portfolio and ranking #4.

Has PRENTISS SMITH & CO INC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), PRENTISS SMITH & CO INC reduced its position in JNJ. The position peaked in Q3 2026 at 35.72K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.